250 related articles for article (PubMed ID: 25765597)
1. Lurasidone for schizophrenia.
Drug Ther Bull; 2015 Mar; 53(3):30-2. PubMed ID: 25765597
[TBL] [Abstract][Full Text] [Related]
2. [Long-term efficacy and safety of lurasidone in the treatment of schizophrenia].
Samalin L; Honciuc M; Llorca PM
Encephale; 2015 Dec; 41(6):541-9. PubMed ID: 26603973
[TBL] [Abstract][Full Text] [Related]
3. Lurasidone in the treatment of schizophrenia: a critical evaluation.
Bruijnzeel D; Yazdanpanah M; Suryadevara U; Tandon R
Expert Opin Pharmacother; 2015; 16(10):1559-65. PubMed ID: 26111577
[TBL] [Abstract][Full Text] [Related]
4. Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders.
Pompili M; Verzura C; Trovini G; Buscajoni A; Falcone G; Naim S; Nardella A; Sorice S; Baldessarini RJ; Girardi P
Expert Opin Drug Saf; 2018 Feb; 17(2):197-205. PubMed ID: 28902525
[TBL] [Abstract][Full Text] [Related]
5. How the pharmacokinetics and receptor-binding profile of lurasidone affect the clinical utility and safety of the drug in the treatment of schizophrenia.
Macaluso M; Kazanchi H; Preskorn SH
Expert Opin Drug Metab Toxicol; 2015; 11(8):1317-27. PubMed ID: 26173973
[TBL] [Abstract][Full Text] [Related]
6. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
[TBL] [Abstract][Full Text] [Related]
7. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
8. Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia.
Meyer JM; Mao Y; Pikalov A; Cucchiaro J; Loebel A
Int Clin Psychopharmacol; 2015 Nov; 30(6):342-50. PubMed ID: 26196189
[TBL] [Abstract][Full Text] [Related]
9. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Citrome L
Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
[TBL] [Abstract][Full Text] [Related]
10. Lurasidone in schizophrenia: new information about dosage and place in therapy.
Citrome L
Adv Ther; 2012 Oct; 29(10):815-25. PubMed ID: 23001538
[TBL] [Abstract][Full Text] [Related]
11. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.
Jaeschke RR; Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Styczeń K; Datka W
Pharmacol Rep; 2016 Aug; 68(4):748-55. PubMed ID: 27203278
[TBL] [Abstract][Full Text] [Related]
12. Lurasidone: a new treatment option for schizophrenia.
Owen RT
Drugs Today (Barc); 2011 Nov; 47(11):807-16. PubMed ID: 22146224
[TBL] [Abstract][Full Text] [Related]
13. Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone.
Corponi F; Fabbri C; Bitter I; Montgomery S; Vieta E; Kasper S; Pallanti S; Serretti A
Eur Neuropsychopharmacol; 2019 Sep; 29(9):971-985. PubMed ID: 31255396
[TBL] [Abstract][Full Text] [Related]
14. Lurasidone-Induced Dystonia.
Tibrewal P; Cheng R; Bastiampillai T; Dhillon R; Okungu A; Campbell J
Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28682525
[No Abstract] [Full Text] [Related]
15. Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis.
Ng-Mak D; Tongbram V; Ndirangu K; Rajagopalan K; Loebel A
J Comp Eff Res; 2018 Aug; 7(8):737-748. PubMed ID: 29697278
[No Abstract] [Full Text] [Related]
16. Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial.
Higuchi T; Iyo M; Kwon JS; Chou YH; Chen HK; Chen JY; Chen TT; Huang SY; Lee JS; Saeki Y; Tanaka H; Wang TS; Wu BJ; Katoh T; Ishigouoka J
Asia Pac Psychiatry; 2019 Sep; 11(3):e12354. PubMed ID: 30912222
[TBL] [Abstract][Full Text] [Related]
17. Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.
Rajagopalan K; Trueman D; Crowe L; Squirrell D; Loebel A
Pharmacoeconomics; 2016 Jul; 34(7):709-21. PubMed ID: 27067724
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.
Greenberg WM; Citrome L
Clin Pharmacokinet; 2017 May; 56(5):493-503. PubMed ID: 27722855
[TBL] [Abstract][Full Text] [Related]
19. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Yang XH; Li L; Zhang QE; Ng CH; Ungvari GS; Li XB; Ning YP; Xiang YT
J Psychiatr Res; 2018 Aug; 103():244-251. PubMed ID: 29906709
[TBL] [Abstract][Full Text] [Related]
20. [Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].
Samalin L; Ben Gharbia M; Garnier M; Llorca PM
Encephale; 2014 Dec; 40(6):507-17. PubMed ID: 25453735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]